Drug profile · INN
faricimab-svoa
VABYSMO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
faricimab-svoa (VABYSMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
Key facts
INN faricimab-svoa
Brand VABYSMO
Route INTRAVITREAL
Formulation INJECTABLE
Frequently asked questions
What is faricimab-svoa?
faricimab-svoa (VABYSMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
What is the brand name for faricimab-svoa?
VABYSMO is a marketed brand name for faricimab-svoa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of faricimab-svoa?
faricimab-svoa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.